{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T18:32:00Z","timestamp":1710354720537},"reference-count":23,"publisher":"Walter de Gruyter GmbH","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_jpm-2022-0019_abs_001\">\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To compare maternal serum midkine (MK) level in pregnant women with idiopathic fetal growth restriction (FGR) and healthy. In addition, we assessed the value of maternal serum MK level in predicting neonatal intensive care unit (NICU) admission.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpm-2022-0019_abs_002\">\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A total of 144 pregnant women were included, 72 with idiopathic FGR and 72 healthy in this study. The control group was matched for the mother\u2019s age, parity, gestational age, and pre-pregnancy body mass index (BMI) with the idiopathic FGR group at the time of recruitment into the study and sample collection.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpm-2022-0019_abs_003\">\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Serum MK level is higher in the idiopathic FGR than the control group (0.24\u00a0ng\/mL (0.19\u20130.32) vs. 0.18\u00a0ng\/mL (0.14\u20130.23), p&lt;0.001). In addition, we compared the maternal serum MK level of those with and without NICU admission in the FGR group (0.25\u00a0ng\/mL (0.19\u20130.37) vs. 0.21\u00a0ng\/mL (0.18\u20130.28), p=0.014). We performed ROC curve analysis to serum MK level predicting NICU admission in the FGR group (AUC: 0.668, %95 CI [0.550, 0.785], p=0.014). A sensitivity of 63% and a specificity of 62% for the serum MK level were achieved with a cut-off value of 0.22 for NICU admission.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpm-2022-0019_abs_004\">\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>To the best of our knowledge, this study is the first to compare maternal serum MK level in pregnant women with idiopathic FGR and healthy. We showed that maternal serum MK level was significantly elevated in pregnant women with FGR than healthy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/jpm-2022-0019","type":"journal-article","created":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T02:34:59Z","timestamp":1653359699000},"page":"396-402","source":"Crossref","is-referenced-by-count":3,"title":["Maternal serum midkine level in fetal growth restriction: a case-control study"],"prefix":"10.1515","volume":"51","author":[{"given":"Deniz","family":"Oluklu","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Perinatology , Turkish Ministry of Health Ankara City Hospital , Cankaya , Ankara , Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilek Menekse","family":"Beser","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Perinatology , Turkish Ministry of Health Ankara City Hospital , Cankaya , Ankara , Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derya Uyan","family":"Hendem","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Perinatology , Turkish Ministry of Health Ankara City Hospital , Cankaya , Ankara , Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozgur","family":"Kara","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Perinatology , Turkish Ministry of Health Ankara City Hospital , Cankaya , Ankara , Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuray","family":"Yazihan","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Internal Medicine , Ankara University Medical School , Cankaya , Ankara , Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilek","family":"Sahin","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Perinatology , Turkish Ministry of Health Ankara City Hospital, University of Health Sciences , Ankara , Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"key":"2023033123593971992_j_jpm-2022-0019_ref_001","doi-asserted-by":"crossref","unstructured":"Miller, J, Turan, S, Baschat, AA. Fetal growth restriction. Semin Perinatol 2008;32:274\u201380. https:\/\/doi.org\/10.1053\/j.semperi.2008.04.010.","DOI":"10.1053\/j.semperi.2008.04.010"},{"key":"2023033123593971992_j_jpm-2022-0019_ref_002","doi-asserted-by":"crossref","unstructured":"Chen, HY, Chauhan, SP, Ward, TC, Mori, N, Gass, ET, Cisler, RA. Aberrant fetal growth and early, late, and postneonatal mortality: an analysis of Milwaukee births, 1996\u20132007. Am J Obstet Gynecol 2011;204:261.e1\u201310. https:\/\/doi.org\/10.1016\/j.ajog.2010.11.040.","DOI":"10.1016\/j.ajog.2010.11.040"},{"key":"2023033123593971992_j_jpm-2022-0019_ref_003","doi-asserted-by":"crossref","unstructured":"Zeitlin, J, Ayoubi, ME, Jarreau, PH, Draper, ES, Blondel, B, K\u00fcnzel, W, et al.. Impact of fetal growth restriction on mortality and morbidity in a very preterm birth cohort. J Pediatr 2010;157:733\u20139.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2010.05.002.","DOI":"10.1016\/j.jpeds.2010.05.002"},{"key":"2023033123593971992_j_jpm-2022-0019_ref_004","doi-asserted-by":"crossref","unstructured":"De Jesus, LC, Pappas, A, Shankaran, S, Li, L, Das, A, Bell, EF, et al.. Outcomes of small for gestational age infants born at <27\u00a0weeks\u2019 gestation. J Pediatr 2013;163:55\u201360.e1\u20133. https:\/\/doi.org\/10.1016\/j.jpeds.2012.12.097.","DOI":"10.1016\/j.jpeds.2012.12.097"},{"key":"2023033123593971992_j_jpm-2022-0019_ref_005","doi-asserted-by":"crossref","unstructured":"Naemi, M, Farahani, Z, Norooznezhad, AH, Khodarahmi, R, Hantoushzadeh, S, Ahangari, R, et al.. Possible potentials of curcumin for pregnancies complicated by intra-uterine growth restriction: role of inflammation, angiogenesis, and oxidative stress. Heliyon 2021;7:e08034. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e08034.","DOI":"10.1016\/j.heliyon.2021.e08034"},{"key":"2023033123593971992_j_jpm-2022-0019_ref_006","doi-asserted-by":"crossref","unstructured":"Hanna, J, Goldman-Wohl, D, Hamani, Y, Avraham, I, Greenfield, C, Natanson-Yaron, S, et al.. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 2006;12:1065\u201374. https:\/\/doi.org\/10.1038\/nm1452.","DOI":"10.1038\/nm1452"},{"key":"2023033123593971992_j_jpm-2022-0019_ref_007","doi-asserted-by":"crossref","unstructured":"Raghupathy, R, Al-Azemi, M, Azizieh, F. Intrauterine growth restriction: cytokine profiles of trophoblast antigen-stimulated maternal lymphocytes. Clin Dev Immunol 2012;2012:734865. https:\/\/doi.org\/10.1155\/2012\/734865.","DOI":"10.1155\/2012\/734865"},{"key":"2023033123593971992_j_jpm-2022-0019_ref_008","doi-asserted-by":"crossref","unstructured":"Weckbach, LT, Muramatsu, T, Walzog, B. Midkine in inflammation. Sci World J 2011;11:2491\u2013505. https:\/\/doi.org\/10.1100\/2011\/517152.","DOI":"10.1100\/2011\/517152"},{"key":"2023033123593971992_j_jpm-2022-0019_ref_009","doi-asserted-by":"crossref","unstructured":"Yazihan, N. Midkine in inflammatory and toxic conditions. Curr Drug Deliv 2013;10:54\u20137. https:\/\/doi.org\/10.2174\/1567201811310010009.","DOI":"10.2174\/1567201811310010009"},{"key":"2023033123593971992_j_jpm-2022-0019_ref_010","doi-asserted-by":"crossref","unstructured":"Cai, YQ, Lv, Y, Mo, ZC, Lei, J, Zhu, JL, Zhong, QQ. Multiple pathophysiological roles of midkine in human disease. Cytokine 2020;135:155242. https:\/\/doi.org\/10.1016\/j.cyto.2020.155242.","DOI":"10.1016\/j.cyto.2020.155242"},{"key":"2023033123593971992_j_jpm-2022-0019_ref_011","doi-asserted-by":"crossref","unstructured":"Obama, H, Tsutsui, J, Ozawa, M, Yoshida, H, Yoshida, Y, Osame, M, et al.. Midkine (MK) expression in extraembryonic tissues, amniotic fluid, and cerebrospinal fluid during mouse embryogenesis. J Biochem 1995;118:88\u201393. https:\/\/doi.org\/10.1093\/oxfordjournals.jbchem.a124896.","DOI":"10.1093\/oxfordjournals.jbchem.a124896"},{"key":"2023033123593971992_j_jpm-2022-0019_ref_012","doi-asserted-by":"crossref","unstructured":"Muramatsu, T. Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases. Proc Jpn Acad Ser B Phys Biol Sci 2010;86:410\u201325. https:\/\/doi.org\/10.2183\/pjab.86.410.","DOI":"10.2183\/pjab.86.410"},{"key":"2023033123593971992_j_jpm-2022-0019_ref_013","doi-asserted-by":"crossref","unstructured":"Yazihan, N, Karakurt, O, Ataoglu, H. Erythropoietin reduces lipopolysaccharide-induced cell damage and midkine secretion in U937 human histiocytic lymphoma cells. Adv Ther 2008;25:502\u201314. https:\/\/doi.org\/10.1007\/s12325-008-0055-5.","DOI":"10.1007\/s12325-008-0055-5"},{"key":"2023033123593971992_j_jpm-2022-0019_ref_014","doi-asserted-by":"crossref","unstructured":"Galan, HenryMD, Grobman, WilliamMD. Fetal growth restriction: ACOG practice bulletin, number 227. Obstet Gynecol 2021;137:e16\u201328.","DOI":"10.1097\/AOG.0000000000004251"},{"key":"2023033123593971992_j_jpm-2022-0019_ref_015","doi-asserted-by":"crossref","unstructured":"Hadlock, FP, Harrist, RB, Sharman, RS, Deter, RL, Park, SK. Estimation of fetal weight with the use of head, body, and femur measurements\u2013a prospective study. Am J Obstet Gynecol 1985;151:333\u20137. https:\/\/doi.org\/10.1016\/0002-9378(85)90298-4.","DOI":"10.1016\/0002-9378(85)90298-4"},{"key":"2023033123593971992_j_jpm-2022-0019_ref_016","doi-asserted-by":"crossref","unstructured":"Yazihan, N, Erol, SA, Akdas, S, Ayhan, SG, Atalay, A, Yildirim, M, et al.. Serum midkine level might be a diagnostic tool for COVID19 disease in pregnancy: from the disease severity, hospitalization and disease progression respects. Cytokine 2022;149:155751. https:\/\/doi.org\/10.1016\/j.cyto.2021.155751.","DOI":"10.1016\/j.cyto.2021.155751"},{"key":"2023033123593971992_j_jpm-2022-0019_ref_017","doi-asserted-by":"crossref","unstructured":"Gordijn, SJ, Beune, IM, Thilaganathan, B, Papageorghiou, A, Baschat, AA, Baker, PN, et al.. Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol 2016;48:333\u20139. https:\/\/doi.org\/10.1002\/uog.15884.","DOI":"10.1002\/uog.15884"},{"key":"2023033123593971992_j_jpm-2022-0019_ref_018","doi-asserted-by":"crossref","unstructured":"Bartha, JL, Romero-Carmona, R, Comino-Delgado, R. Inflammatory cytokines in intrauterine growth retardation. Acta Obstet Gynecol Scand 2003;82:1099\u2013102. https:\/\/doi.org\/10.1046\/j.1600-0412.2003.00259.x.","DOI":"10.1046\/j.1600-0412.2003.00259.x"},{"key":"2023033123593971992_j_jpm-2022-0019_ref_019","doi-asserted-by":"crossref","unstructured":"Wixey, JA, Chand, KK, Colditz, PB, Bjorkman, ST. Review: neuroinflammation in intrauterine growth restriction. Placenta 2017;54:117\u201324. https:\/\/doi.org\/10.1016\/j.placenta.2016.11.012.","DOI":"10.1016\/j.placenta.2016.11.012"},{"key":"2023033123593971992_j_jpm-2022-0019_ref_020","doi-asserted-by":"crossref","unstructured":"Oluklu, D, Beser, DM, Hendem, DU, Sinaci, S, Turgut, E, Yazihan, N, et al.. Maternal serum midkine level increases in pregnant women with diabetes mellitus: a case-control study. Gynecol Endocrinol 2022;38:329\u201332. https:\/\/doi.org\/10.1080\/09513590.2022.2045937. 35236197.","DOI":"10.1080\/09513590.2022.2045937"},{"key":"2023033123593971992_j_jpm-2022-0019_ref_021","doi-asserted-by":"crossref","unstructured":"Nawathe, A, Lees, C. Early onset fetal growth restriction. Best Pract Res Clin Obstet Gynaecol 2017;38:24\u201337. https:\/\/doi.org\/10.1016\/j.bpobgyn.2016.08.005.","DOI":"10.1016\/j.bpobgyn.2016.08.005"},{"key":"2023033123593971992_j_jpm-2022-0019_ref_022","doi-asserted-by":"crossref","unstructured":"Lees, CC, Romero, R, Stampalija, T, Dall\u2019Asta, A, DeVore, GA, Prefumo, F, et al.. Clinical opinion: the diagnosis and management of suspected fetal growth restriction: an evidence-based approach. Am J Obstet Gynecol 2022;226:366\u201378. https:\/\/doi.org\/10.1016\/j.ajog.2021.11.1357.","DOI":"10.1016\/j.ajog.2021.11.1357"},{"key":"2023033123593971992_j_jpm-2022-0019_ref_023","doi-asserted-by":"crossref","unstructured":"Georgiou, HM, Thio, YS, Russell, C, Permezel, M, Heng, YJ, Lee, S, et al.. Association between maternal serum cytokine profiles at 7\u201310\u00a0weeks\u2019 gestation and birthweight in small for gestational age infants. Am J Obstet Gynecol 2011;204:415.e1\u201312. https:\/\/doi.org\/10.1016\/j.ajog.2010.12.005.","DOI":"10.1016\/j.ajog.2010.12.005"}],"container-title":["Journal of Perinatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpm-2022-0019\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpm-2022-0019\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T13:36:25Z","timestamp":1680356185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpm-2022-0019\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":23,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,8,8]]},"published-print":{"date-parts":[[2023,3,28]]}},"alternative-id":["10.1515\/jpm-2022-0019"],"URL":"https:\/\/doi.org\/10.1515\/jpm-2022-0019","relation":{},"ISSN":["0300-5577","1619-3997"],"issn-type":[{"value":"0300-5577","type":"print"},{"value":"1619-3997","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,25]]}}}